CIRCULATING MIRNA-122, MIRNA-155, AND MIRNA- 200 AS PREDICTORS FOR HEPATOCELLULAR CARCINOMA OCCURRENCE IN EGYPTIAN PATIENTS WITH HEPATITIS C RELATED LIVER CIRRHOSIS TREATED WITH

Plasma MicroRNAs as Biomarkers for HCV Related Hepatocellular ‎Carcinoma: Diagnostic Performance of a microRNA Panel in Egyptian ‎Patients‎ ‎

Evaluation of Circulating MicroRNA 483-5p as a Useful Diagnostic Tool of Hepatocellular Carcinoma in Egyptian Patients

CIRCULATING MICRORNA-615-5P AS A DIAGNOSTIC MOLECULAR MARKER IN EGYPTIAN PATIENTS WITH LIVER CIRRHOSIS

Molecular Diagnosis of Hepatocellular Carcinoma in Egypt

DETECTION OF FIBRONECTIN IN SERA OF HCV INFECTED PATIENTS WITH LIVER FIBROSIS

ROLE OF PRI-MIR-34 B/C AND MIR-146A POLYMORPHISM IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C

Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients

Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients

MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma